Speaker
Cheryl Anne Boyce, PhD
ASSOCIATE COMMISSIONER FOR MINORITY HEALTH - OFFICE OF MINORITY HEALTH AND HEALTH EQUITY, FDA
Dr. Cheryl Anne Boyce is the Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. Food and Drug Administration. In this role, Dr. Boyce provides leadership, oversight, and direction on minority health and health disparity matters for the agency and leads collaborative strategic initiatives that advance health equity, including OMHHE’s Enhance Equity Initiative and the Racial and Ethnic Minority Acceleration Consortium for Health Equity (REACH) Initiative.
Dr. Boyce came to the FDA from the National Institutes of Health (NIH) where she served as the Assistant Director for Re-engineering the Research Enterprise in the Office of Strategic Coordination, The Common Fund, Division of Program Coordination, Planning, and Strategic Initiatives. There she was involved with and helped lead multiple transformative, translational, synergistic NIH programs for reengineering clinical research and the workforce.
At NIH, Dr. Boyce also oversaw several programs for the Common Fund, including the Transformative Research to Address Health Disparities and Advance Health Equity initiative. This collaborative effort is designed to increase the competitiveness of investigators and expand the research base dedicated to health disparities research, including low-resourced institutions and Minority-Serving Institutions. She also led the development and implementation of the Common Fund’s Community Partnerships to Advance Science for Society (ComPASS) program, a first-of-its-kind community-led and community-driven initiative. The ComPASS funds community organizations directly to work with partners to conduct health equity research intervening on social determinants of health and structural factors shaping conditions of everyday life.
Dr. Boyce received her doctorate and master’s degrees in clinical psychology from The University of North Carolina at Chapel Hill, and a bachelor’s, cum laude in psychology, with University Honors in the Social Sciences from The Catholic University of America.
Dr. Boyce came to the FDA from the National Institutes of Health (NIH) where she served as the Assistant Director for Re-engineering the Research Enterprise in the Office of Strategic Coordination, The Common Fund, Division of Program Coordination, Planning, and Strategic Initiatives. There she was involved with and helped lead multiple transformative, translational, synergistic NIH programs for reengineering clinical research and the workforce.
At NIH, Dr. Boyce also oversaw several programs for the Common Fund, including the Transformative Research to Address Health Disparities and Advance Health Equity initiative. This collaborative effort is designed to increase the competitiveness of investigators and expand the research base dedicated to health disparities research, including low-resourced institutions and Minority-Serving Institutions. She also led the development and implementation of the Common Fund’s Community Partnerships to Advance Science for Society (ComPASS) program, a first-of-its-kind community-led and community-driven initiative. The ComPASS funds community organizations directly to work with partners to conduct health equity research intervening on social determinants of health and structural factors shaping conditions of everyday life.
Dr. Boyce received her doctorate and master’s degrees in clinical psychology from The University of North Carolina at Chapel Hill, and a bachelor’s, cum laude in psychology, with University Honors in the Social Sciences from The Catholic University of America.
Speaking In
3:00 PM - 4:15 PM
Tuesday, November 19